Use of TP modulators for the treatment of cardiovascular disorders in aspirin sensitive and other populations

Details for Australian Patent Application No. 2008247439 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Homcy, Charles J.; Andre, Patrick; Phillips, David R.

Agent Davies Collison Cave

Pub. Number AU-A-2008247439

PCT Pub. Number WO2008/137791

Priority 60/947,289 29.06.07 US; 60/947,316 29.06.07 US; 60/915,785 03.05.07 US; 60/915,784 03.05.07 US

Filing date 2 May 2008

Wipo publication date 13 November 2008

International Classifications

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2008/137791 Priority application(s): WO2008/137791

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008247441-Unit dose formulations and methods of treating and preventing thrombosis with thromboxane receptor antagonists

2008247438-Cleaning compositions containing water soluble magnesium compound and methods of using them